Mechanism of interaction between antineoplastic agents and natural differentiation factors in the induction of human leukemic cell maturation

Cancer Research

Volumn 46, Issue , 1986, Pages 6311-6315

  Honma, Yoshio ^a   Honma, Chieko ^a   Bloch, Alexander ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DACTINOMYCIN; DAUNORUBICIN; MESSENGER RNA; RADIOISOTOPE;

BLOOD AND HEMOPOIETIC SYSTEM; CELL CULTURE; DIAGNOSIS; DIFFERENTIATION; DRUG INTERACTION; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MYELOID LEUKEMIA; NORMAL HUMAN; ONCOGENE; PRIORITY JOURNAL; RNA SYNTHESIS;

ANTINEOPLASTIC AGENTS; BLOOD PHYSIOLOGY; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA; DAUNORUBICIN; HUMAN; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOCYTES; PROTO-ONCOGENES; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022848638     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bloch, A. Induced cell differentiation in cancer therapy. Cancer Treat. Rep., 68: 199-206, 1984.
2. Hozumi, M. Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation. Adv. Cancer Res., 38: 121-169,1983.
3. Sachs, L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukemia. Nature (Lond.), 274: 535-539 1978.
4. Craig, R.W., Frankfurt, O.S., Sakagami, H., Takeda, K., and Bloch, A. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells. Cancer Res., 44: 2421–2429, 1984.
5. Takeda, K., Minowada, J., and Bloch, A. Differential ability of mitogen-stimulated human leukocyte-conditioned media to induce Fc receptors in human leukemia cells. Cell Immunol., 79: 288-297,1983.
6. Takeda, K., Minowada, J., and Bloch, A. Kinetics of appearance of differ-entiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-O-tetradecanoylphorbol- 13-acetate, dimethyl sulfoxide, or 1-β-D-arabinofuranosylcytosine. Cancer Res., 42: 5152–5158, 1982.
7. Sakagami, H., Hromchak, R., and Bloch, A. Prevention of phorbol ester receptor down modulation in human myeloblastic leukemia ML-1 cells by differentiation-stimulating serum components. Cancer Res., 44: 3330-3335, 1984.
8. Bresser, J., Doering, J., and Gillespie, D. Quick-blot: Selective mRNA or DNA immobilization from whole cells. DNA, 2: 243-254, 1983.
9. Craig, R.W., and Bloch, A. Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-O-tetradecanoylphorbol- 13-acetate. Cancer Res., 44: 442-446,1984.
10. Dani, C., Blanchard, J. M., Piechaczyk, M., El Sabouty, S., Marty, L., and Jeanteur, P. Extreme instability for myc mRNA in normal and transformed human cells. Proc. Natl. Acad. Sci. USA, 81: 7046-7050 1984.
11. Ramsay, G., Evan, G. I. and Bishop, J. M. The protein encoded by the human proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA, 81: 7742–7746, 1984.
12. Thompson, C.B., Challoner, P.B., Neiman, P.E., and Groudine, M. Expression of the c-myb proto-oncogene during cellular proliferation. Nature (Lond.), 319: 374-380,1986.
13. Pardee, A.B., Campisi, J., Gray, H.E., Dean, M. and Sonenshein, G. Cellular oncogenes, growth factors, and cellular growth controls. In: Mediators in Cell Growth and Differentiation. University of Texas M. D. Anderson Symposium on Fundamental Cancer Research, 37: 21-30, 1984.
14. Campisi, J., Medrano, E. E., Morreo, J., and Pardee, A. B. Restriction point control of cell growth by a labile protein: evidence for increased stability in transformed cells. Proc. Natl. Acad. Sci. USA, 79: 436-4401, 1982.
15. Kafatos, F.C. mRNA stability and cellular differentiation. Karolinska Symp. Reprod. Endocrinol., 5: 319–345, 1972.
16. Hayashi, M., Okabe, J., and Hozumi, M. Sensitization of resistant myeloid leukemia cells by anticancer drugs to factor-stimulating differentiation. Gann, 70: 235–238, 1979.
17. Okabe, J., Honma, Y., and Hozumi, M. Differentiation of a resistant clone of mouse myeloid leukemia cells with dimethyl sulfoxide and ascitic fluid. Gann, 68: 151-157, 1977.
18. Okabe, J., Honma, M., and Hozumi, M. Actinomycin D restores in vivo sensitivity to differentiation induction of non-differentiating mouse myeloid leukemia cells. Int. J. Cancer, 24: 87-91,1979.
19. Gonda, T.J., and Metcalf, D. Expression of myb, myc and fos proto-oncogenes during differentiation of a murine myeloid leukemia. Nature (Lond.), 310: 249-251,1984.
20. Mitchell, R.L., Zokas, L., Schreiber, R.D., and Verma, I.M. Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation. Cell, 40: 209-217,1985.
21. Sariban, E., Mitchell, T., and Kufe, D. Expression of the c-fms proto-oncogene during human monocytic differentiation. Nature (Lond.), 316: 64-66,1985.
22. Westin, E.H., Gallo, R.C., Arya, S.K., Eva, A., Souza, L.M., Baluda, M.A., Aaronson, S.A., and Wong-Staal, F. Differential expression of the amv gene in human hematopoietic cells. Proc. Natl. Acad. Sci. USA, 79: 2194–2198, 1982.
23. Westin, E.H., Wong-Staal, F., Gelman, E.P., Favera, R.D., Papas, T.S., Lautenberger, J.A., Eva, A., Reddy, E.P., Trenik, S.R., Aaronson, S.A., and Gallo, R.C. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc. Natl. Acad. Sci. USA, 79: 2490–2494, 1982.
24. Honma, Y., Kasukabe, T., Okabe, J., and Hozumi, M. Prolongation of survival time of mice inoculated with myeloid leukemia cells by inducers of normal differentiation. Cancer Res., 39: 3167-3171,1979.
25. Honma, Y., Okabe, J., Kasukabe, T., and Hozumi, M. Survival of mice inoculated with non-differentiating myeloid leukemia cells is prolonged by the injection of an inducer of cell differentiation with a sensitizer. Gann, 71: 543–547, 1980.